BNP Paribas Financial Markets’s BioSpecifics Technologies Corp. BSTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,464
| Closed | -$77.3K | – | 4258 |
|
|
2020
Q3 | $77.3K | Buy |
1,464
+1,164
| +388% | +$71.8K | ﹤0.01% | 3251 |
|
|
2020
Q2 | $18.4K | Sell |
300
-1,607
| -84% | -$92.9K | ﹤0.01% | 3431 |
|
|
2020
Q1 | $108K | Buy |
1,907
+980
| +106% | +$55.8K | ﹤0.01% | 3162 |
|
|
2019
Q4 | $52.8K | Sell |
927
-27
| -3% | -$1.43K | ﹤0.01% | 3625 |
|
|
2019
Q3 | $51.1K | Buy |
954
+302
| +46% | +$17.6K | ﹤0.01% | 3465 |
|
|
2019
Q2 | $38.9K | Sell |
652
-553
| -46% | -$34.8K | ﹤0.01% | 3582 |
|
|
2019
Q1 | $75.1K | Buy |
1,205
+1,203
| +60,150% | +$79.6K | ﹤0.01% | 3281 |
|
|
2018
Q4 | $121 | Sell |
2
-178
| -99% | -$10.6K | ﹤0.01% | 4161 |
|
|
2018
Q3 | $10.5K | Hold |
180
| – | – | ﹤0.01% | 3707 |
|
|
2018
Q2 | $8.07K | Sell |
180
-987
| -85% | -$42.5K | ﹤0.01% | 3883 |
|
|
2018
Q1 | $51.7K | Buy |
1,167
+61
| +6% | +$2.56K | ﹤0.01% | 3546 |
|
|
2017
Q4 | $47.9K | Buy |
1,106
+637
| +136% | +$28.6K | ﹤0.01% | 3684 |
|
|
2017
Q3 | $21.8K | Sell |
469
-92
| -16% | -$4.41K | ﹤0.01% | 3550 |
|
|
2017
Q2 | $27.8K | Buy |
+561
| New | +$29.4K | ﹤0.01% | 3476 |
|
|
2017
Q1 | – | Sell |
-34
| Closed | -$1.89K | – | 4306 |
|
|
2016
Q4 | $1.89K | Sell |
34
-367
| -92% | -$17.6K | ﹤0.01% | 3925 |
|
|
2016
Q3 | $18.3K | Buy |
401
+190
| +90% | +$7.63K | ﹤0.01% | 2943 |
|
|
2016
Q2 | $8.43K | Buy |
211
+177
| +521% | +$6.48K | ﹤0.01% | 2994 |
|
|
2016
Q1 | $1.18K | Sell |
34
-1,004
| -97% | -$36.8K | ﹤0.01% | 2487 |
|
|
2015
Q4 | $44.6K | Buy |
1,038
+62
| +6% | +$3.11K | ﹤0.01% | 2885 |
|
|
2015
Q3 | $42.5K | Buy |
976
+566
| +138% | +$30.5K | ﹤0.01% | 2984 |
|
|
2015
Q2 | $21.2K | Buy |
410
+318
| +346% | +$13.6K | ﹤0.01% | 3014 |
|
|
2015
Q1 | $3.6K | Buy |
+92
| New | +$3.61K | ﹤0.01% | 3315 |
|
|
2014
Q4 | – | Sell |
-124
| Closed | -$4.38K | – | 3523 |
|
|
2014
Q3 | $4.38K | Buy |
+124
| New | +$3.64K | ﹤0.01% | 3839 |
|
|
2014
Q2 | – | Sell |
-186
| Closed | -$4.41K | – | 4003 |
|
|
2014
Q1 | $4.41K | Hold |
186
| – | – | ﹤0.01% | 2432 |
|
|
2013
Q4 | $4.03K | Buy |
+186
| New | +$3.81K | ﹤0.01% | 3243 |
|
Other funds holding BSTC
BNP Paribas Financial Markets's BSTC Position: Q4 2020 in Review
BNP Paribas Financial Markets sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 1,464 shares — an estimated $77.3K sold.
BNP Paribas Financial Markets first reported a position in BSTC in Q4 2013 and held it in 25 quarters. The position peaked at $108K in Q1 2020. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.
- BNP Paribas Financial Markets reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
- BNP Paribas Financial Markets sold 1,464 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $77.3K.
- BNP Paribas Financial Markets first reported a position in BioSpecifics Technologies Corp. in Q4 2013 and held it in 25 quarters.
- BNP Paribas Financial Markets's BioSpecifics Technologies Corp. position peaked at $108K in Q1 2020.
- 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2020, filed 10 Feb 2021.